Comparison of Preoperative and Postoperative Serum 25-Hydroxyvitamin D Levels and Vitamin K–Dependent Blood Coagulation Factor Profiles in Patients Undergoing Cholecystectomy Authors: Nedim Akgul, Burak Sakar, Mehmet Ilker Turan, Kemal Eyvaz, Onur Ilkay Dincer, Erhan Aydemir Published: 2026 ABSTRACT BackgroundCholecystectomy alters enterohepatic bile circulation, impairing fat-soluble vitamin absorption and reducing bioavailability of vitamin D and vitamin K, required for hepatic synthesis of coagulation factors II, VII, IX, and X. Despite the high global frequency of this procedure, evidence regarding clinically significant postoperative changes in fat-soluble vitamin status remains inconsistent. This retrospective single-center study compared preoperative and postoperative serum 25-hydroxyvitamin D (25[OH]D) levels and vitamin K–dependent coagulation profiles in patients undergoing cholecystectomy.Material/MethodsAll data were retrieved from electronic medical records of patients who underwent cholecystectomy between January 2020 and January 2025. Two distinct cohorts were formed: the vitamin K cohort (n = 101), in which prothrombin time (PT), activated partial thromboplastin time (aPTT), and international normalized ratio (INR) were evaluated at ≥ 7 days postoperatively; and the 25(OH)D cohort (n = 78), in which serum 25(OH)D levels were evaluated at ≥ 3 months postoperatively. Patients with comorbidities or medications affecting these parameters were excluded.ResultsIn the 25(OH)D cohort, no significant difference was found between preoperative and postoperative median levels (19.76 vs 19.13 μg/L, P = 0.248). In the vitamin K cohort, no significant changes were detected in PT (11.80 vs 11.67 s, P = 0.301), aPTT (29.83 vs 30.40 s, P = 0.131), or INR (1.03 vs 1.03, P = 0.859). Sex-stratified analyses revealed no significant differences.ConclusionsCholecystectomy was not associated with a clinically significant decline in serum 25(OH)D or alterations in vitamin K–dependent coagulation profiles. Postoperative insufficiencies appear driven by pre-existing metabolic risk profiles. Clinical management should prioritize preoperative metabolic optimization over routine post-surgical supplementation. Introduction Cholecystectomy is one of the most frequently performed abdominal surgical procedures worldwide, predominantly performed via the laparoscopic approach, and is regarded as the gold standard in the surgical management of symptomatic gallstone disease [1]. It has been reported that more than 750 000 cholecystectomies are performed annually in the United States alone, underscoring the clinical importance of understanding the long-term physiological and metabolic consequences of this common operation [1]. Bile plays a pivotal role in fat digestion and in the intestinal absorption of fat-soluble vitamins (A, D, E, and K); bile acids are essential for the micellar solubilization and chylomicron-mediated transport of these vitamins [2,3]. After cholecystectomy, the gallbladder’s reservoir and concentration functions are eliminated, leading to continuous delivery of non-concentrated bile into the duodenum. In some patients, this physiological alteration is associated with post-cholecystectomy diarrhea, particularly after fatty meals [4]. It is hypothesized that alterations in fat absorption dynamics following cholecystectomy may also influence the bioavailability of fat-soluble vitamins [2]. Vitamin K absorption relies on bile salt and pancreatic lipase to facilitate the digestion and absorption of dietary fats. Vitamin K is indispensable for the post-translational γ-carboxylation and activation of vitamin K–dependent blood coagulation factors II, VII, IX, and X. Its deficiency can manifest as prolongation of prothrombin time (PT) and elevation of the international normalized ratio (INR) [5,6]. Similarly, 25-hydroxy vitamin D (25[OH]D) plays an important role in many metabolic activities, primarily bone tissue metabolism; it reaches its biologically active form (1,25[OH]2D) through sequential conversions occurring in the liver and kidneys [7]. For assessing vitamin D status, measurement of serum 25(OH)D—the most stable circulating marker with a half-life of approximately 2 to 3 weeks—is recommended [8]. Beyond their classical digestive functions, bile acids act as signaling molecules through nuclear and membrane receptors, modulating gut hormone secretion and influencing glucose and lipid homeostasis [9,10]. Classical physiological evidence and some clinical studies suggest that cholecystectomy may alter enterohepatic bile acid circulation dynamics and potentially reduce circulating 25(OH)D concentrations [11]. However, an unresolved knowledge gap persists in the current surgical literature; existing evidence regarding post-cholecystectomy changes in fat-soluble vitamin absorption remains highly inconsistent and limited, lacking absolute consensus on whether the altered anatomy translates into a clinically significant, chronic deficiency state. Investigating these postoperative alterations is of profound public health and clinical relevance, as undetected long-term deficiencies could lead to severe systemic consequences, including impaired bone mineral density, accelerated osteoporosis, or a silent predisposition to altered coagulation and bleeding diathesis. Furthermore, vitamins D and K were selected as the primary target markers in this study because they are the only fat-soluble vitamins for which direct or indirect clinical measurements can be routinely and reliably performed within standard hospital laboratory infrastructure. This practical availability, coupled with the fact that they represent distinct, critical physiological pathways dependent on continuous biliary micellar solubilization—bone and metabolic homeostasis and the hepatic coagulation cascade, respectively—makes them highly sensitive and feasible clinical indicators of fat malabsorption compared with other fat-soluble vitamins. Therefore, this retrospective study from a single center aimed to compare preoperative and postoperative serum 25(OH)D levels and vitamin K–dependent blood coagulation factor profiles in 101 patients undergoing cholecystectomy. Material and Methods Ethical Approval and Study Design This single-center, retrospective, observational study was approved by the Clinical Research Ethics Committee of Antalya Training and Research Hospital, University of Health Sciences (ethics committee approval No: 2025-288; approval date: September 11, 2025). The study was conducted in full accordance with the principles of the Declaration of Helsinki and applicable research publication ethics guidelines. Due to the retrospective and observational design of the study, the requirement for obtaining written informed consent was explicitly waived by the Clinical Research Ethics Committee, ensuring full data confidentiality. All data were obtained exclusively from institutional electronic medical records; no prospective patient contact was required for data collection purposes. Medical records of patients who underwent cholecystectomy for gallstone disease between January 2020 and January 2025 were retrospectively analyzed. Data Source and Patient Identification All clinical and laboratory data were extracted from the institutional electronic medical records (EMR) system of Antalya Training and Research Hospital. The EMR system contains complete documentation of outpatient clinic visits, hospitalization records, operative notes, discharge summaries, and laboratory test results generated by the institutional central laboratory. Patient identification was performed by searching the surgical database for all cholecystectomy procedures coded under the relevant International Classification of Diseases (ICD) codes during the defined study period. Postoperative laboratory values were identified through the EMR by linking each patient’s unique identifier to outpatient follow-up visits or subsequent hospitalizations during which the relevant measurements were obtained. When EMR were incomplete regarding supplementation or comorbidity status, telephone interviews were conducted with patients or their caregivers for confirmation. Inclusion and Exclusion Criteria As illustrated in the study flowchart (Figure 1), patients were selected through strict, sequential screening steps from an initial pool of 5434 individuals. For the vitamin K cohort (group K), patients with both preoperative and at least 1 postoperative (≥ postoperative day 7) measurement of PT, aPTT, and INR were included, considering the limited tissue stores of vitamin K and the potential for blood coagulation changes to become detectable within days [12]. Patients lacking either preoperative or postoperative values for these parameters were excluded. Additional exclusion criteria included incomplete demographic data, use of any anticoagulant medication, chronic kidney disease, malignancy, known coagulopathy, and chronic liver or pancreatic disease. Exclusion criteria were verified through the EMR system; telephone interviews were conducted when necessary for confirmation. For the 25(OH)D cohort (group D), patients aged 18 years or older with both a preoperative and at least 1 postoperative (≥ 3 months after surgery) 25(OH)D measurement were included. Measurement timing was standardized because 25(OH)D is the clinically relevant marker with a half-life of approximately 2 to 3 weeks. Patients without the required measurements or with missing demographic/follow-up data were excluded. Patients with conditions predisposing to malabsorption, including chronic pancreatitis, chronic heavy alcohol use, inflammatory bowel disease, and prior gastrointestinal surgery, were not enrolled. To reduce the confounding effect of sunlight exposure, only individuals residing in the city where the center is located were included. Patients who received vitamin D supplementation between the 2 measurements, or who had osteoporosis, bisphosphonate therapy, estrogen or estrogen-progestin treatment, parathyroid dysfunction, renal or hepatic impairment, or pregnancy were excluded due to potential confounding effects on 25(OH)D or calcium metabolism. Supplementation status and other exclusion criteria were confirmed via electronic prescription records and, when needed, telephone contact. Data Collection and Laboratory Assays Age, sex, comorbidities, surgery date, discharge date, medication history, and procedure-related clinical data were extracted from the institutional database. Laboratory data comprised preoperative and postoperative (≥ 7 days) PT, aPTT, and INR values for group K, and preoperative and postoperative (≥ 3 months) 25(OH)D concentrations for group D. It is important to note that all laboratory analyses were performed by the same institutional central laboratory throughout the entire study period (2020–2025), using consistent, standardized equipment and the same reference ranges, thereby minimizing inter-laboratory variability. All serum 25(OH)D levels were determined using a standardized electrochemiluminescence immunoassay autoanalyzer, while blood coagulation parameters (PT, aPTT, INR) were measured via an automated coagulation analyzer using standard commercial reagents. Standard calibration and daily quality control protocols were strictly maintained by the institutional central laboratory to ensure measurement accuracy. All comparisons were performed within each cohort (preoperative vs postoperative). The reference range for 25(OH)D used by our laboratory was < 20 μg/L, indicating deficiency, 20–29 μg/L, indicating insufficiency, and ≥ 30 μg/L, indicating sufficiency, consistent with current Endocrine Society guidelines [13]. Statistical Analysis Data were analyzed using IBM SPSS (Statistical Package for the Social Sciences) Statistics for Windows, version 27.0 (IBM Corp, Armonk, NY, USA). Normality of continuous variables was evaluated using the Shapiro-Wilk and Kolmogorov-Smirnov tests. Missing data were managed using a complete-case analysis approach; patients with any missing baseline or follow-up laboratory parameters were systematically excluded during the initial screening phase. Normally distributed variables were compared using the paired t test (for within-group preoperative vs postoperative comparisons) or the independent samples t test (for between-group sex comparisons), as appropriate, and their values are expressed as mean ± standard deviation (SD). Non-normally distributed variables were compared using the Wilcoxon signed-rank test (within-group) or the Mann-Whitney U test (between-group), and their values are expressed as median with interquartile range (IQR). Potential systemic confounders were addressed through strict exclusion criteria, geographic matching for solar exposure, and detailed sex-stratified subgroup analyses. A 2-tailed P value < 0.05 was considered statistically significant. Results Demographic Characteristics A total of 5434 patients who underwent cholecystectomy between January 2020 and January 2025 were retrospectively analyzed. After applying inclusion and exclusion criteria, 101 patients were included in group K and 78 patients in group D, as sequentially detailed in the study flow diagram (Figure 1). Demographic characteristics of both cohorts are summarized in Table 1. Mean age was 53.53 ± 12.95 years in group D and 52.39 ± 15.92 years in group K, with a predominance of female patients in both groups (71.8% and 68.3%, respectively) and comparable body mass index (BMI) values (Table 1). Pre- and Postoperative Laboratory Results Pre- and postoperative laboratory values, analyzed independently of sex, showed no statistically significant variations across all parameters (Table 2). The median preoperative serum 25(OH)D level was 19.76 μg/L (IQR 10.62–36.32) and postoperatively it was 19.13 μg/L (IQR 12.41–26.22; P = 0.248). Similarly, blood coagulation parameters showed no significant alterations: preoperative PT was 11.80 ± 1.21 seconds vs 11.67 ± 1.21 seconds postoperatively (P = 0.301), aPTT was 29.83 ± 3.27 seconds vs 30.40 ± 3.85 seconds (P = 0.131), and INR values were 1.03 ± 0.10 vs 1.03 ± 0.11 (P = 0.859) (Table 2). Sex-Stratified Subgroup Analyses Sex-stratified subgroup analyses are presented in Table 3. In group D, female patients had a median preoperative 25(OH)D level of 16.31 μg/L (IQR 9.34–35.05) and a postoperative level of 23.28 μg/L (IQR 16.83–39.35; P = 0.145), while male patients had a median preoperative level of 17.27 μg/L (IQR 11.25–25.19) and a postoperative level of 21.68 μg/L (IQR 16.16–36.16; P = 0.337). In group K, female patients had aPTT values of 29.71 ± 3.56 seconds preoperatively and 30.16 ± 3.50 seconds postoperatively (P = 0.330), while male patients had aPTT values of 30.07 ± 2.57 seconds vs 30.92 ± 4.52 seconds (P = 0.219). Female patients had PT values of 11.77 ± 1.14 seconds preoperatively and 11.54 ± 1.21 seconds postoperatively (P = 0.172), whereas male patients had PT values of 11.89 ± 1.37 seconds vs 11.93 ± 1.19 seconds (P = 0.857). Pre- and postoperative INR values were 1.03 ± 0.10 vs 1.02 ± 0.11 for female patients (P = 0.725) and 1.03 ± 0.12 vs 1.04 ± 0.11 for male patients (P = 0.816) (Table 3). Discussion In the present study, we compared preoperative and postoperative serum 25(OH)D levels and vitamin K–dependent blood coagulation parameters (PT, aPTT, INR) in patients who underwent cholecystectomy for gallstone disease. The principal finding was that neither serum 25(OH)D concentrations nor any vitamin K–sensitive coagulation parameter showed a statistically or clinically significant change following surgery, and this stability was consistently observed across both the overall and sex-stratified analyses. These findings advance current knowledge by addressing a critical gap regarding the clinical significance of altered bile flow dynamics on fat-soluble vitamin absorption, and they directly refute the expectation that cholecystectomy inevitably induces a clinically meaningful state of fat-soluble vitamin malabsorption. Vitamin K is critical for γ-carboxylation of coagulation factors II, VII, IX, and X; deficiency can lead to bleeding diathesis and may increase morbidity in subsequent surgical interventions [12]. Published data directly examining vitamin K absorption and coagulation test changes after cholecystectomy are limited; indirect evaluation via PT, aPTT, and INR is therefore clinically relevant. Continuous, non-concentrated bile flow after cholecystectomy has been suggested to impair optimal absorption of fat-soluble vitamins, including vitamin K [14]. The time course of INR prolongation in vitamin K deficiency is typically 2 to 5 days [12,15]. Accordingly, we evaluated values obtained at least 7 days postoperatively, yet no significant differences were found. A recent study by Kumar et al examined coagulation profile changes in patients undergoing laparoscopic cholecystectomy with CO2 pneumoperitoneum and observed that the pneumoperitoneum itself may transiently affect coagulation parameters intraoperatively; however, no persistent clinically significant coagulopathy was reported postoperatively [16]. This observation is consistent with our finding that, in a carefully selected patient population, cholecystectomy does not produce clinically meaningful early-term or intermediate-term coagulopathy secondary to altered vitamin K absorption. There are conflicting findings in the literature regarding 25(OH)D levels after cholecystectomy [17–19]. Polat et al reported lower 25(OH)D levels and bone mineral density in postmenopausal women who had undergone cholecystectomy [20]. Similarly, a single-center case-control study by Ekiz et al reported that 25(OH)D levels might be lower in individuals after cholecystectomy [21]. Conversely, in a nationwide cohort study, Nielsen et al found that the risk of osteoporosis was not increased after cholecystectomy [17], while a recent systematic review and meta-analysis by Sun et al reported only a small association between cholecystectomy and fracture risk, with high heterogeneity regarding osteoporosis outcomes [18]. These discrepancies underscore that 25(OH)D levels can be significantly influenced by strong confounding factors such as sun exposure, diet, comorbidities like obesity, and especially pancreatic function. Furthermore, since the half-life of 25(OH)D is approximately 2 to 3 weeks, and the body can store sufficient 25(OH)D for approximately 3 months, standardizing the timing of postoperative measurement is of critical importance [13]. The primary limitations in prior studies making it difficult to establish a direct relationship with cholecystectomy include population heterogeneity, lack of temporal standardization, and insufficient exclusion of malabsorption-predisposing factors. Within this framework, our study showed that 25(OH)D levels were below normal values in a significant portion of patients both preoperatively and after the third postoperative month. Thus, although a high baseline prevalence of vitamin D insufficiency was observed in both groups, cholecystectomy did not provoke further clinical decline. This systemic stability aligns with contemporary cohorts suggesting that the human hepatobiliary system successfully compensates for the loss of gallbladder reservoir function. When the entire cohort was evaluated, 25(OH)D levels did not show a significant change beyond the third postoperative month compared with the preoperative period, and this finding persisted in both sex-stratified subgroups. Additionally, cholelithiasis is associated with lipid profile irregularities, fiber-deficient diets, inadequate physical activity, and obesity; it has been shown that a sedentary lifestyle and unhealthy nutrition can lead to dysfunction in biliary activity [22,23]. Therefore, it may not always be appropriate to characterize vitamin anomalies in individuals who have undergoing cholecystectomy as being solely secondary to the surgery, as these patients are not comparable to the general population with regard to their metabolic and nutritional profiles. Indeed, a cohort analysis by Lee et al reported that the risk of fracture may be higher in individuals having undergone cholecystectomy; however, the cholecystectomy group also had higher rates of hypertension, diabetes mellitus, dyslipidemia, obesity, and smoking [22], underscoring the importance of the comorbidity burden and metabolic risk profile in fracture risk interpretations. On the other hand, in the present study, the vitamin K–related assessment (PT, aPTT, INR) and the 25(OH)D assessment were conducted in sub-cohorts selected from the same patient pool; these sub-cohorts were not compared against each other, and the preoperative-to-postoperative change within each cohort was evaluated independently. While this approach offers the advantage of examining 2 different clinical outcomes separately, the lack of direct vitamin K serum level or functional marker measurements and the inability to quantitatively evaluate variables such as sun exposure and dietary fat intake for group D, may limit interpretations. Limitations The present study has several limitations that should be acknowledged when interpreting its findings. First, the retrospective, single-center design inherently limits the generalizability of the results, as selection bias and unmeasured confounders cannot be fully excluded despite stringent exclusion criteria. Second, because all clinical and laboratory data were obtained from institutional electronic medical records, potential inconsistencies in documentation, coding practices, or changes in ancillary clinical management over the 5-year study period represent a methodological limitation of retrospective data collection; however, all laboratory analyses were performed at a single institutional central laboratory using consistent equipment and reference ranges throughout the study period, which mitigates inter-laboratory variability. Third, the laboratory reference ranges and equipment used were specific to our institution, and, while all analyses were performed under standardized conditions, minor differences in assay calibration across time points cannot be entirely ruled out. Fourth, the sample sizes—particularly in group D (n = 78)—are relatively small, which may limit the statistical power to detect modest effect sizes. Fifth, direct serum vitamin K levels (eg, phylloquinone/vitamin K1) or functional markers such as undercarboxylated prothrombin were not measured; coagulation parameters (PT, aPTT, INR) served as indirect indicators of vitamin K status. Similarly, quantitative evaluation of dietary fat intake, ultraviolet light exposure, metabolic syndrome markers, and menopausal status was not possible within the retrospective framework. Sixth, postoperative follow-up data were obtained through existing outpatient laboratory records; patients who did not return for routine follow-up and who therefore lacked postoperative measurements were excluded, potentially introducing a healthy responder bias. Finally, this study does not include imaging findings from individual patients, as this was a laboratory-based retrospective cohort study; all outcome parameters were biochemical rather than radiological, and individual imaging studies were not part of the study protocol. Future prospective, multicenter, longitudinal studies incorporating direct functional vitamin assays, quantitative dietary monitoring, precise ultraviolet exposure measurement, and longer follow-up periods are warranted to validate and extend these findings. Conclusions In conclusion, this retrospective single-center study demonstrates that, within a standardized follow-up framework with rigorous exclusion of confounders, cholecystectomy is not associated with a clinically significant decline in serum 25(OH)D levels or alterations in vitamin K–dependent coagulation profiles. These findings imply that postoperative vitamin insufficiencies are primarily driven by pre-existing metabolic risk profiles and baseline lifestyle factors rather than the surgical removal of the gallbladder. Consequently, patient management should shift away from routine post-surgical vitamin monitoring toward comprehensive preoperative risk stratification, dietary counseling, and metabolic lifestyle interventions. Future research must utilize larger prospective cohorts with strict confounder controls and direct functional vitamin assays to definitively validate these long-term metabolic dynamics.